Cargando…

Influence of Dosing Interval and Administration on the Bone Metabolism, Skeletal Effects, and Clinical Efficacy of Parathyroid Hormone in Treating Osteoporosis: A Narrative Review

Recombinant human parathyroid hormone (PTH) is the key anabolic agent used for preventing fracture in postmenopausal women with osteoporosis. In bone metabolism, PTH signaling is mediated through a G protein–coupled receptor that affects various post‐receptor signaling pathways. Results of preclinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyoung Min, Lee, Sae Young, Rhee, Yumie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124169/ https://www.ncbi.nlm.nih.gov/pubmed/30283879 http://dx.doi.org/10.1002/jbm4.10005

Ejemplares similares

Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation
por: Osagie-Clouard, L., et al.
Publicado: (2017)

Effects of Intermittent Administration of Parathyroid Hormone and Parathyroid Hormone‐Related Protein on Fracture Healing: A Narrative Review of Animal and Human Studies
por: Yamashita, Junro, et al.
Publicado: (2019)

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
por: Pearson, Richard G., et al.
Publicado: (2019)

Histological and histomorphometric aspects of continual intermittent parathyroid hormone administration on osseointegration in osteoporosis rabbit model
por: Oki, Yoshifumi, et al.
Publicado: (2022)

Optimal intermittent administration interval of parathyroid hormone 1‐34 for bone morphogenetic protein‐induced bone formation in a rat spinal fusion model
por: Abe, Tetsutaro, et al.
Publicado: (2021)

UK Reference Intervals for Parathyroid Hormone Using Abbott Methods
por: Mirzazadeh, Mehdi, et al.
Publicado: (2023)

The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Migliaccio, Silvia, et al.
Publicado: (2007)

Factors associated with osteoporosis medication initiation and adherence
por: Rhee, Yumie
Publicado: (2018)

Effect of high-frequency loading and parathyroid hormone administration on peri-implant bone healing and osseointegration
por: Shibamoto, Aya, et al.
Publicado: (2018)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
por: Jódar-Gimeno, Esteban
Publicado: (2007)

Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia
por: Braverman, Eric R, et al.
Publicado: (2009)

Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
por: Gong, M., et al.
Publicado: (2023)

ODP132 Efficacy of Romosozumab for Osteoporosis in a Patient with Hajdu-Cheney Syndrome: A Case Report
por: Kim, Kyoung Jin, et al.
Publicado: (2022)

Update on Preoperative Parathyroid Localization in Primary Hyperparathyroidism
por: Park, Hye-Sun, et al.
Publicado: (2022)

Feasibility and Efficacy of Autologous Bone Marrow Aspirate Transplantation Combined with Human Parathyroid Hormone 1-34 Administration to Treat Osteonecrosis in a Rabbit Model
por: Makihara, Takeshi, et al.
Publicado: (2017)

Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization‐induced bone loss
por: Harlow, Lauren, et al.
Publicado: (2017)

Use of Recombinant Human Parathyroid Hormone to Treat Hungry Bone Syndrome in Hemodialysis Patient
por: Ahmed, Chaaban, et al.
Publicado: (2020)

Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical bone
por: Ogura, Kenji, et al.
Publicado: (2016)

Parathyroid Hormone versus Bisphosphonate Treatment on Bone Mineral Density in Osteoporosis Therapy: A Meta-Analysis of Randomized Controlled Trials
por: Shen, Longxiang, et al.
Publicado: (2011)

In Vitro & In Vivo Effect of Parathyroid Hormone Analogue (1-14) Containing α-amino-iso-butyric Acid Residue (Aib)(1,3)
por: Rhee, Yumie, et al.
Publicado: (2006)

Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy
por: Frieling, Jeremy S., et al.
Publicado: (2019)

Triweekly administration of parathyroid hormone (1–34) accelerates bone healing in a rat refractory fracture model
por: Kumabe, Yohei, et al.
Publicado: (2017)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

DNA damage checkpoint pathway modulates the regulation of skeletal growth and osteoblastic bone formation by parathyroid hormone-related peptide
por: Zhang, Ying, et al.
Publicado: (2018)

The Efficacy of Parathyroid Hormone Analogues in Combination With Bisphosphonates for the Treatment of Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
por: Li, Wan, et al.
Publicado: (2015)

Efficacy and safety of recombinant human parathyroid hormone (1–34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
por: Deng, Jing, et al.
Publicado: (2018)

Intermittent parathyroid hormone treatment affects the bone structural parameters and mechanical strength of the femoral neck after ovariectomy-induced osteoporosis in rats
por: Wang, Shun-Ping, et al.
Publicado: (2022)

Parathyroid Hormone-Related Peptide (PTHrP): Evaluation of Pediatric, Covariate-Stratified Reference Intervals
por: Brescia, Vincenzo, et al.
Publicado: (2022)

Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model
por: Oki, Yoshifumi, et al.
Publicado: (2017)

Parathyroid Hormone Administration Improves Bone Marrow Microenvironment and Partially Rescues Haematopoietic Defects in Bmi1-Null Mice
por: Lu, Ruinan, et al.
Publicado: (2014)

Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
por: Kimura, Shigemi, et al.
Publicado: (2014)

The Effects of Parathyroid Hormone Applied at Different Regimes on the Trochanteric Region of the Femur in Ovariectomized Rat Model of Osteoporosis
por: Tezval, M., et al.
Publicado: (2011)

Recombinant Human Parathyroid Hormone Related Protein 1-34 and 1-84 and Their Roles in Osteoporosis Treatment
por: Wang, Hua, et al.
Publicado: (2014)

Parathyroid hormone's enhancement of bones' osteogenic response to loading is affected by ageing in a dose- and time-dependent manner
por: Meakin, Lee B, et al.
Publicado: (2017)

Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
por: Pietrogrande, Luca
Publicado: (2010)

The serum level of 25-hydroxyvitamin D for maximal suppression of parathyroid hormone in children: the relationship between 25-hydroxyvitamin D and parathyroid hormone
por: Kang, Jung In, et al.
Publicado: (2017)

Relationship between Vitamin D, Parathyroid Hormone, and Bone Mineral Density in Elderly Koreans
por: Kim, Guilsun, et al.
Publicado: (2012)

Bone responsiveness to parathyroid hormone is negatively associated with parathyroid hormone-lowering drug use in patients undergoing hemodialysis: a cross-sectional study
por: Tominaga, Naoto, et al.
Publicado: (2021)

Parathyroid venous sampling for the preoperative localisation of parathyroid adenoma in patients with primary hyperparathyroidism
por: Ho, Joon, et al.
Publicado: (2022)

The Parathyroid Hormone-Related Protein/Parathyroid Hormone 1 Receptor Axis in Adipose Tissue
por: Izquierdo-Lahuerta, Adriana
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5nhe1c3olsj3cneiiibquvqrg